What is Redhill Biopharma Ltd (RDHL) stock price today?

Redhill Biopharma Ltd (RDHL) currently trades at $1.04 per share. The stock has a market capitalization of $5.27M and a P/E ratio of 0.00x.

Is RDHL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Redhill Biopharma Ltd has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Redhill Biopharma Ltd's revenue and earnings?

Redhill Biopharma Ltd has trailing twelve-month (TTM) revenue of $9.55M with profit margins of -97.50%. Earnings per share (EPS) is $0.00.

RDHL

Redhill Biopharma Ltd

NASDAQ: RDHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.04

+0.00% today

Updated 2026-04-29

Market cap

$5.27M

P/E ratio

0.00

P/S ratio

0.55x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$1 – $3

Volume

0.0M

Market cap

$5.27M

P/E ratio

0.00

P/S ratio

0.55x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$1 – $3

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$19,000.00

+1826823.08%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 58.60% QoQ

Risks

- Thin margins at -97.50%

- Negative free cash flow $-9.66M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$85.76M	$61.80M	$6.53M	$8.04M	$9.55M
Net income	$-97.74M	$-71.67M	$23.92M	$-8.27M	$-2.07M
EPS	—	—	—	—	$0.00
Free cash flow	$-29.38M	$-35.83M	$-9.38M	$-9.66M	$-9.66M
Profit margin	-113.98%	-115.97%	366.25%	-102.80%	-97.50%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RDHL	$5.27M	31	5.3	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Redhill Biopharma Ltd trades at $1.04. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $9.55M. with profit margins at -97.50%.

Frequently asked questions

What is Redhill Biopharma Ltd's stock price?

Redhill Biopharma Ltd (RDHL) trades at $1.04.

Is Redhill Biopharma Ltd overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Redhill Biopharma Ltd (RDHL)?

The analyst target price is $19,000.00, representing +1826823.1% upside from the current price of $1.04.

What is Redhill Biopharma Ltd's revenue?

TTM revenue is $9.55M.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.55x

ROE-1,709.00%

Beta4.92

50D MA$0.89

200D MA$1.28

Shares out0.01B

Float14.93B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RDHL vs LLY →RDHL vs JNJ →RDHL vs ABBV →Stock screener →